NO20013725L - Anvendelsen av antikonvulsive derivater for behandling av bulimi nervosa - Google Patents

Anvendelsen av antikonvulsive derivater for behandling av bulimi nervosa

Info

Publication number
NO20013725L
NO20013725L NO20013725A NO20013725A NO20013725L NO 20013725 L NO20013725 L NO 20013725L NO 20013725 A NO20013725 A NO 20013725A NO 20013725 A NO20013725 A NO 20013725A NO 20013725 L NO20013725 L NO 20013725L
Authority
NO
Norway
Prior art keywords
treatment
bulimia nervosa
anticonvulsant derivatives
anticonvulsant
derivatives
Prior art date
Application number
NO20013725A
Other languages
English (en)
Norwegian (no)
Other versions
NO20013725D0 (no
Inventor
Scott P Hoopes
Original Assignee
Ortho Mcneil Pharm Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ortho Mcneil Pharm Inc filed Critical Ortho Mcneil Pharm Inc
Publication of NO20013725D0 publication Critical patent/NO20013725D0/no
Publication of NO20013725L publication Critical patent/NO20013725L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Epidemiology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
NO20013725A 1999-02-01 2001-07-30 Anvendelsen av antikonvulsive derivater for behandling av bulimi nervosa NO20013725L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US11805799P 1999-02-01 1999-02-01
PCT/US2000/002334 WO2000044374A1 (en) 1999-02-01 2000-01-31 Use of anticonvulsant derivatives for treating bulimia nervosa

Publications (2)

Publication Number Publication Date
NO20013725D0 NO20013725D0 (no) 2001-07-30
NO20013725L true NO20013725L (no) 2001-07-30

Family

ID=22376270

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20013725A NO20013725L (no) 1999-02-01 2001-07-30 Anvendelsen av antikonvulsive derivater for behandling av bulimi nervosa

Country Status (23)

Country Link
EP (1) EP1148874B1 (xx)
JP (1) JP2002535363A (xx)
KR (1) KR100664618B1 (xx)
CN (1) CN1196482C (xx)
AR (1) AR029331A1 (xx)
AT (1) ATE255892T1 (xx)
AU (1) AU764703B2 (xx)
BR (1) BR0007897A (xx)
CA (1) CA2360677C (xx)
CZ (1) CZ295594B6 (xx)
DE (1) DE60007078T2 (xx)
DK (1) DK1148874T3 (xx)
ES (1) ES2211507T3 (xx)
HU (1) HUP0105420A3 (xx)
IL (1) IL144407A0 (xx)
MX (1) MXPA01007758A (xx)
NO (1) NO20013725L (xx)
NZ (1) NZ513114A (xx)
PT (1) PT1148874E (xx)
TR (1) TR200102205T2 (xx)
TW (1) TW565446B (xx)
WO (1) WO2000044374A1 (xx)
ZA (1) ZA200107212B (xx)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6890951B2 (en) 1998-08-05 2005-05-10 Brookhaven Science Associates Llc Treatment of addiction and addiction-related behavior
ES2238999T3 (es) * 1999-02-24 2005-09-16 University Of Cincinnati Uso de derivados de sulfamato para tratar trastornos en el control de los impulsos.
AU2002227052A1 (en) 2000-11-30 2002-06-11 University Of Florida Treatments for neurogenetic disorders, impulse control disorders, and wound healing
US6462084B1 (en) 2001-05-14 2002-10-08 Brookhaven Science Associates, Llc Treatment for obsessive-compulsive disorder (OCD) and OCD-related disorders using GVG
US8652527B1 (en) 2013-03-13 2014-02-18 Upsher-Smith Laboratories, Inc Extended-release topiramate capsules
US9101545B2 (en) 2013-03-15 2015-08-11 Upsher-Smith Laboratories, Inc. Extended-release topiramate capsules

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4513006A (en) * 1983-09-26 1985-04-23 Mcneil Lab., Inc. Anticonvulsant sulfamate derivatives
IT1248588B (it) * 1991-06-28 1995-01-19 Gaetano Crepaldi Composizioni farmaceutiche per la terapia dell'astinenza, del " craving", della dipendenza da sostanze stupefacenti, da sostanze psicoattive, da nicotina e dei disturbi alimentari.

Also Published As

Publication number Publication date
KR20010101665A (ko) 2001-11-14
DE60007078D1 (de) 2004-01-22
DK1148874T3 (da) 2004-03-29
KR100664618B1 (ko) 2007-01-04
BR0007897A (pt) 2001-10-30
ES2211507T3 (es) 2004-07-16
PT1148874E (pt) 2004-04-30
ZA200107212B (en) 2002-12-02
TW565446B (en) 2003-12-11
TR200102205T2 (tr) 2002-01-21
EP1148874A1 (en) 2001-10-31
CN1196482C (zh) 2005-04-13
CA2360677C (en) 2005-07-05
ATE255892T1 (de) 2003-12-15
AU764703B2 (en) 2003-08-28
NO20013725D0 (no) 2001-07-30
WO2000044374A1 (en) 2000-08-03
MXPA01007758A (es) 2003-06-24
NZ513114A (en) 2003-10-31
DE60007078T2 (de) 2004-12-16
EP1148874B1 (en) 2003-12-10
HUP0105420A3 (en) 2003-03-28
JP2002535363A (ja) 2002-10-22
CZ295594B6 (cs) 2005-08-17
AU2746200A (en) 2000-08-18
IL144407A0 (en) 2002-05-23
CA2360677A1 (en) 2000-08-03
AR029331A1 (es) 2003-06-25
HUP0105420A2 (hu) 2002-05-29
CN1338931A (zh) 2002-03-06

Similar Documents

Publication Publication Date Title
NO20014379D0 (no) Anvendelse av Xenon for behandling av Neurointoksikasjoner
NO20013369D0 (no) Arylpiperazinyl-cykloheksyl-indol-derivater for behandling av depresjon
NO20013380L (no) 2-aminobenzoksazinonderivater for behandling av fedme
NO20021474L (no) Forbindelser for behandling av ischemi
ATE283733T1 (de) Beschichtungsverfahren
NO20022087L (no) Fremgangsmåte for behandling av diabetes
NO20013381D0 (no) 2-oksybenzoksazinonderivater for behandling av fedme
NO20020358D0 (no) Anvendelse av etodolac for behandling av kreft
PT1246817E (pt) Derivados de 4-fenil-1-piperazinilo, -piperidinilo e -tetra-hidropiridilo
PT1022396E (pt) Combinacao de duche
ID26097A (id) Proses pembuatan pakaian luar sekali pakai
FI990509A0 (fi) Häiriönpoistomenetelmä
NO20013725L (no) Anvendelsen av antikonvulsive derivater for behandling av bulimi nervosa
NO20012541D0 (no) Anvendelse av fosfonomaursyrederivater for behandling av infeksjoner
PT1178984E (pt) Derivados de 1-trifluorometil-4-hidroxi-7-piperidinilamimometilcromano
NO20020059D0 (no) Fremgangsmåte for fremstilling av dibenzotiazepinderivater
NO20012612D0 (no) Isonipecotamider for behandling av integren-formidlede lidelser
NO20013995D0 (no) Fremgangsmate for fremstilling av L-sorbose
NO20014845D0 (no) Anvendelse av arylalkanoylpyridaziner
NO20022956L (no) Fremgangsmate for fremstilling av nitroguanidin
NO20012540D0 (no) Anvendelse av fosfonomaursyrederivater for behandling av infeksjoner
NO986053D0 (no) Antikonvulsive derivater for behandling av psoriasis
NO20014477D0 (no) Behandling av osteoartritis
NO20020328D0 (no) Fremgangsmåte for fremstilling av 4-cyano-2-aminometyltiazol
NO20020327D0 (no) Fremgangsmåte for fremstilling av 2-aminometyl-4-cyano-tiazol

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application